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Available online 3 December 2014Manganese (Mn) is an essential trace element contributing
to various physiological processes like brain development,
diverse metabolisms and proper function of antioxidative
enzymes like Acetylcholinesterase (AchE) (Erikson et al.,
2005). On the downside, overexposure to Mn can lead to the
degeneration of dopaminergic neurons inducing a Parkinson-
like complaint called manganism. Extensive studies have
been carried out to decipher transport routes into the
brain and to detect cellular mechanisms of oxidative injury0.1016/j.pisc.2014.11.023
ublished by Elsevier GmbH. This is an open access
mons.org/licenses/by-nc-nd/3.0/).
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a have already been published in Metallomics,
4MT00022F: Manganese leads to an increase in
stress as well as to a shift in the ratio of Fe(II)/(III)
thor.
atharina.Fernsebner@helmholtz-muenchen.dein the affected brain areas (Crossgrove et al., 2003; Yokel,
2009; Yokel and Crossgrove, 2004; Aschner et al., 2007).
Nevertheless, the correlation between the active Mn-
species and the occurring conceivable causes of oxidative
injury has not been drawn so far. The aim of this study is
therefore, to elucidate the predominant Mn-species in the
exposed brain and link it to levels of glutamate or GABA,
AchE activity, Fe(II)/(III) status and levels of other trace
elements like Cu, Fe or Zn (Figure 1).
The applied model was a feeding trial of rats, where Mn
levels were elevated (500 mg/kg) in a non-toxic manner in
the test group and which lasted for 53 days.
After removal of the brain, it was deep frozen and
roughly homogenized. Levels of Mn, Cu, Fe and Zn were
determined in the whole brain by ICP-OES or –MS. Mn levels
were signiﬁcantly higher in Mn-exposed (test) rats compared
to normal exposed (control) rats, which was interestingly
also true for Cu levels. Furthermore an aqueous extraction
of the brain served as matrix for determination of AchE
activity as well as glutamate and GABA levels by commercial
available kits. Test rats showed signiﬁcantly elevated AchE
activity as well as increased glutamate levels, indicating
oxidative stress in the affected brain tissue (Erikson and
Aschner, 2003; Melo et al., 2003). The same brain extracts
were applied for determination of the Fe(II)/(III) status byarticle under the CC BY-NC-ND license
Figure 1 Aim of the study: Correlation of active Mn-species
with levels of AchE activity and glutamate, with Fe(II)/(III)
ratios as well as markers of oxidative stress due to Mn exposure
in rats.
37Explorating the mechanismIC-ICP-OES. Interestingly, a signiﬁcant shift of the Fe(II)/(III)
ratio in favor of Fe(II) was observed in Mn-exposed rat brain
extracts. The increase in highly reactive Fe(II) might there-
fore contribute to Mn-induced neurotoxicity by facilitating
oxidative stress via the Fenton reaction (Sadrzadeh and
Saffari, 2004). In addition, a MeOH extraction of the brain
served for FT-ICR-MS measurement for targeted analysis of
markers for oxidative stress. Main differences could be
observed for levels of GSSG, PGB1 and PGH2 as well as
15(S)–HETE, a marker of lipid peroxidation. These metabolites
were signiﬁcantly increased in test samples due to oxidative
stress and inﬂammation in the brain.
The next step will be the correlation of these ﬁndings to
the active Mn-species in the brain, which is still in progress
by SEC-ICP-MS. Future work will include local distribution ofMn in the brain by LA-ICP-MS of brain sections as well as the
comparison of this oral with an i.v. injected exposure to Mn.
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